Researchers have demonstrated that inebilizumab reduced the risk of symptoms by 87 percent in patients with the rare affliction known as immunoglobulin G4-related disease (IgG4-RD).
InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, today announced that the Committee for Medicinal Products for Human ...
“Hospital-acquired and septic infections are one of the risk factors that may increase the predispositions to future neuroinflammatory and neurocognitive impairments, especially in older adults,” ...
Kids and teens are more likely to be infected than healthy adults, but adults with weakened ... Most people get better without needing special treatment. You can help prevent it by keeping your ...
There are cases in which RSV infection has progressed to serious lung infections and pneumonia ... people can remain contagious for up to four weeks after symptoms resolve. Most cases of RSV in adults ...
Sometimes, a doctor may also recommend treatment for gonorrhea because the bacteria that cause the two infections can occur together. To diagnose chlamydia, a doctor may carry out an examination ...